Polypectomy – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:31:53 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Polypectomy – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Short-term Interruption vs. Continuous Anticoagulation with Apixaban in Patients Undergoing Colorectal Polypectomy https://clinicaltrials.eu/trial/study-on-short-term-interruption-vs-continuous-anticoagulation-with-apixaban-in-patients-undergoing-colorectal-polypectomy/ Wed, 29 Apr 2026 14:28:19 +0000 https://clinicaltrials.eu/trial/study-on-short-term-interruption-vs-continuous-anticoagulation-with-apixaban-in-patients-undergoing-colorectal-polypectomy/ This clinical trial is focused on patients who are taking oral anticoagulant medications and are scheduled for a planned colonoscopy, a procedure to examine the inside of the colon. The study is investigating the safety of continuing anticoagulation treatment during the removal of polyps, which are small growths in the colon. The medications being studied include Apixaban, Acenocoumarol, Dabigatran Etexilate, Warfarin, Rivaroxaban, and Edoxaban. These medications are used to prevent blood clots and are known as anticoagulants.

The purpose of the study is to evaluate whether it is safe to maintain anticoagulation treatment during the removal of polyps in the colon. Participants in the study will either continue their anticoagulation medication or have a short-term interruption of the medication during the procedure. The study will monitor for any bleeding or clotting events after the procedure to determine the safety of each approach.

This trial is designed to help understand the best way to manage anticoagulation treatment during colonoscopy procedures, ensuring patient safety while effectively preventing blood clots. The study is expected to run until May 2026, with recruitment starting in May 2024.

]]> Study on the Safety of Continuing Apixaban, Clopidogrel, and Rivaroxaban During Polyp Removal in Patients on Antiplatelet or Anticoagulant Therapy https://clinicaltrials.eu/trial/study-on-the-safety-of-continuing-apixaban-clopidogrel-and-rivaroxaban-during-polyp-removal-in-patients-on-antiplatelet-or-anticoagulant-therapy/ Wed, 29 Apr 2026 14:27:41 +0000 https://clinicaltrials.eu/trial/study-on-the-safety-of-continuing-apixaban-clopidogrel-and-rivaroxaban-during-polyp-removal-in-patients-on-antiplatelet-or-anticoagulant-therapy/ This clinical trial is focused on patients who need a colonoscopy and are taking medications called antiplatelets or anticoagulants. These medications help prevent blood clots but can increase the risk of bleeding. The study will look at the safety of continuing these medications during a procedure called a cold snare polypectomy, which is used to remove small, non-pedunculated colorectal polyps. The main goal is to see if the risk of bleeding after the procedure is similar whether patients continue their medication or stop it according to current medical guidelines.

The trial will involve several medications, including Apixaban, Clopidogrel, Rivaroxaban, Dabigatran Etexilate, Edoxaban, and Acenocoumarol. These medications are taken orally, meaning they are swallowed in pill form. The study will compare the effects of these medications on bleeding risks during and after the polypectomy procedure. Some patients will continue their medication, while others will stop taking it as per usual medical practice.

The study will last for a period of up to eight weeks for each participant. During this time, participants will undergo the polypectomy procedure and be monitored for any signs of bleeding or other complications. The aim is to ensure that continuing these medications does not increase the risk of significant bleeding compared to stopping them. This information will help doctors make better decisions about managing medications during such procedures in the future.

]]>